ph2
This week we are looking at the CV system and pharmacology
This week you may again choose your own case from this list:
Case Study 1:
Patient AO has a history of obesity and has recently gained 9 pounds. The patient has been diagnosed with hypertension and hyperlipidemia. Drugs currently prescribed include the following:
Atenolol 12.5 mg daily
Doxazosin 8 mg daily
Hydralazine 10 mg qid
Sertraline 25 mg daily
Simvastatin 80 mg daily
Case Study 2:
Patient HM has a history of atrial fibrillation and a transient ischemic attack (TIA). The patient has been diagnosed with type 2 diabetes, hypertension, hyperlipidemia and ischemic heart disease. Drugs currently prescribed include the following:
Warfarin 5 mg daily MWF and 2.5 mg daily T, TH, Sat, Sun
Aspirin 81 mg daily
Metformin 1000 mg po bid
Glyburide 10 mg bid
Atenolol 100 mg po daily
Motrin 200 mg 1–3 tablets every 6 hours as needed for pain
Case Study 3:
Patient CB has a history of strokes. The patient has been diagnosed with type 2 diabetes, hypertension, and hyperlipidemia. Drugs currently prescribed include the following:
Glipizide 10 mg po daily
HCTZ 25 mg daily
Atenolol 25 mg po daily
Hydralazine 25 mg qid
Simvastatin 80 mg daily
Verapamil 180 mg CD daily Reference: ACC/ACHA
Guideline on the Management of Blood Cholesterol
http://www.onlinejacc.org/content/accj/73/24/e285.full.pdf?_ga=2.211926493.853299748.1583090983-768093126.1583090983
Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults
http://www.onlinejacc.org/content/accj/71/19/e127.full.pdf?_ga=2.119020992.853299748.1583090983-768093126.1583090983
Guideline on the Primary Prevention of Cardiovascular Disease
http://www.onlinejacc.org/content/accj/74/10/e177.full.pdf?_ga=2.120069185.853299748.1583090983-768093126.1583090983
Guideline for the Management of Patients With Atrial Fibrillation
http://www.onlinejacc.org/content/accj/74/1/104.full.pdf?_ga=2.181500014.853299748.1583090983-768093126.1583090983
Guideline for the Management of Heart Failure
http://www.onlinejacc.org/content/accj/70/6/776.full.pdf?_ga=2.182392302.853299748.1583090983-768093126.1583090983
Strategies to Enhance Application of Clinical Practice Guidelines in Patients With Cardiovascular Disease and Comorbid Conditions
http://www.onlinejacc.org/content/accj/64/17/1851.full.pdf?_ga=2.174568939.853299748.1583090983-768093126.1583090983
Effectiveness-Based Guidelines for the Prevention of Cardiovascular Disease in Women
http://www.onlinejacc.org/content/accj/57/12/1404.full.pdf?_ga=2.214857950.853299748.1583090983-768093126.1583090983
Guideline for the Evaluation and Management of Patients With Syncope
http://www.onlinejacc.org/content/accj/70/5/e39.full.pdf?_ga=2.186086496.853299748.1583090983-768093126.1583090983